health surveillance
health surveillance health surveillance
health surveillance
health surveillance
health surveillance
health surveillance
health surveillance health surveillance health surveillance health surveillance health surveillance health surveillance health surveillance health surveillance health surveillance health surveillance health surveillance health surveillance health surveillance  
health surveillance
health surveillance
health surveillance

health surveillance

health surveillance
Home
First Release
Previous Release
Next Release
News Index
Sitemap
sickness absence management
remote case management
occupational health
PEQs PEQ
pre employment questionnaires
outsourcing occupational health
EAP
preemployment questionnaires
health promotion days
health promotion
- Net loss in the third quarter, excluding reorganization expenses and impairment of fixed assets and goodwill, was $2.2 million, or $0.12 diluted loss per share. Net loss including non-recurring items totaled $22.8 million, or $1.22 diluted loss per-share. - Positive operating cash flow in the third quarter was $9.1 million. - Operating profit in Q3 2005, before reorganization expenses and impairment of fixed assets and goodwill, amounted to zero. - Further to the announcement given with the second quarter result Delta instituted a reorganization plan and impairment of fixed assets and goodwill that resulted in a charge of $20.6 million ($1.10 per share), or $21.5 million before tax in the third quarter of 2005. - The Company expects that the full implementation of the reorganization plan will take 12 months and therefore, be concluded during the third quarter of 2006. TEL AVIV, Israel, Nov. 15 /PRNewswire-FirstCall/ -- Delta Galil Industries Ltd. (Nasdaq: DELT), ("Delta") the global provider of private label ladies intimate apparel, socks, mens underwear, baby-wear and leisurewear, today reported third quarter 2005 revenues of $172.0 million, a decrease of 3% compared to the $176.5 million in revenues reported in the third quarter of 2004. Revenues, excluding Burlen, decreased by 17% in the third quarter compared to the same period in 2004. In the first nine months of 2005, sales increased 6% to $514.3 million, compared to $487.1 in the first nine months of 2004. Revenues, excluding Burlen, in the first nine months decreased by 12% compared to the first nine months last year. Net loss for the third quarter of 2005 was $22.8 million or $1.22 diluted loss per share, compared to net income of $5.0 million or $0.27 diluted earnings per share in the third quarter last year. The net loss in the third quarter of 2005 includes reorganization expenses and impairment of fixed assets and goodwill in a total charge of $20.6 million ($1.10 per share), or $21.5 million before tax. Excluding reorganization expenses and impairments of fixed assets and goodwill, net loss for the third quarter was $2.2 million or $0.12 diluted loss per share. Net loss for the first nine months of 2005 was $28.7 million or $1.54 diluted loss per share, compared to net income of $12.9 million or $0.68 per share for the same period last year. Excluding reorganization expenses and impairments of fixed assets and goodwill, net loss for the first nine months was $7.9 million or $0.42 diluted loss per share. Operating cash flow in the third quarter of 2005 was positive $9.1 million compared to negative operating cash flow of $2.8 million in the third quarter of 2004. In the first nine months of 2005, operating cash flow was positive $0.6 million compared to negative cash flow of $8.3 million in the first nine months of 2004. Sales by geographic area ($ million) Third Quarter Nine Months Ended September 30 % of % of % of % of total total % total total % 2005 sales 2004 sales Chg. 2005 sales 2004 sales Chg North Amer- ica(1) 102.8 59.8 96.9 54.9 6.1 305.6 59.5 251.1 51.6 21.7 Europe 55.2 32.1 67.2 38.1 (17.9) 169.9 33.0 200.2 41.1 (15.1) Israel 14.0 8.1 12.4 7.0 12.9 38.8 7.5 35.8 7.3 8.4 ----- ---- ----- ----- ----- ----- ----- ----- ----- ----- Total 172.0 100.0 176.5 100.0 (2.6) 514.3 100.0 487.1 100.0 5.6 (1) North Americas revenues, excluding Burlen sales, decreased in the third quarter and in the first nine months of 2005 by 20% and 12% compared to the same periods last year. Sales and operating results by divisions ($ million) Third Quarter Impairment Operating Reorgani of Impairment Sales Profit -zation Fixed of % (loss) Expenses Assets Goodwill 2005 2004 Chg. 2005 2004 2005 2005 2005 Delta USA(1) 70.3 55.2 27.3 3.1 3.2 1.3 1.5 U.S. Upper market 25.5 33.6 (24.2) (1.5) 0.5 1.6 5.9 2.1 Europe 40.7 50.7 (19.7) (1.2) 2.1 1.5 Socks -US & Europe 29.2 32.7 (10.9) (1.1) 1.3 4.1 3.4 Delta Marketing Israel 12.9 11.0 17.2 1.6 1.2 Adjust- ments(2) (6.6) (6.7) (0.9) 0.4 0.1 ----- ----- ----- ----- ----- ----- ----- Consolidated 172.0 176.5 (2.6) -- 8.7 8.6 7.4 5.5 ===== ===== ===== ===== ===== ===== ===== Impairment of Fixed Assets 7.4 Reorganization expenses 8.6 Impairment of Goodwill 5.5 Total Consolidated Operating profit (loss) (21.5) 8.7 Nine Months Ended September 30 Impairment Operating Reorgani of Impairment Sales Profit -zation Fixed of % (loss) Expenses Assets Goodwill 2005 2004 Chg. 2005 2004 2005 2005 2005 Delta USA(1) 208.5 140.4 48.5 7.1 7.5 1.3 1.5 U.S. Upper market 75.1 88.5 (15.1) (10.3) 0.8 1.6 5.9 2.1 Europe 121.5 146.9 (17.3) (3.2) 6.5 2.0 Socks- US & Europe 93.1 103.4 (10.0) 0.7 5.9 4.1 3.4 Delta Marketing Israel 35.8 31.6 13.3 3.7 2.7 Adjust- ments(2) (19.7) (23.7) (1.3) (1.4) 0.1 ----- ----- ----- ----- ----- ----- ----- Consolidated 514.3 487.1 5.6 (3.3) 22.0 9.1 7.4 5.5 ===== ===== ===== ===== ===== ===== ===== Impairment of Fixed Assets 7.4 Reorganization expenses 9.1 Impairment of Goodwill 5.5 Total Consolidated Operating profit (loss) (25.3) 22.0 (1) Including $25.2 and $84.6 million of Burlen sales in the third quarter and in the first nine months of 2005. Excluding Burlen, sales decreased by 18% and 12% respectively, compared to the same periods last year. (2) The adjustment item includes in sales: sales between divisions and forward transactions results. In operating profit, it includes mainly the establishment expenses of the new plant in China, capital gains, cancellation of unrealized profits and forward transactions results Mr. Arnon Tiberg, Deltas CEO, stated, "The primary reason for the decrease in sales and in profits in the third quarter and the first nine months of the year is the erosion of selling prices to some of our customers particularly in our European operation in Marks & Spencer and in the U.S upper market. This erosion reduced Deltas sales and operating profit by approximately $40 million this year, compared to 2004 on an annual basis. We are in a period of major changes in the global business environment. Following the elimination of quotas as part of the WTO agreement, the market has been characterized by strong pressure to lower prices. We are investing major efforts to increase our brands activity and in implementing improvements in fabrics and products. In addition we are entering new categories in existing and new customers. We expect these actions to increase sales in the future". Reorganization Plan and impairment of Fixed Assets and Goodwill Following the change in the business environment and the erosion in selling prices, Delta decided to implement a reorganization plan designed to cut costs, increase efficiency and return to profitability. "We believe that full implementation of the reorganization plan as reported in the second quarter, along with reducing the cost of procurement will decrease costs and help to offset a large portion of the selling price reduction," stated Mr. Tiberg. The implementation of the reorganization plan is expected to last 12 months and to end during the third quarter of 2006. The expected cost of this plan is included in the third quarter of 2005 and amounts to $20.6 million ($1.10 per share), or $21.5 million before tax, and includes the following: 1. Reorganization plan in a total amount of $8.6 million. The Plan includes the closing of manufacturing plants in Central and North America and in Israel that will result in the dismissal of approximately 2,000 workers. This amount includes $6.0 million in cash which will be used mainly for severance payments and $2.6 million in non-cash for impairment of fixed assets following the closures and reduction of activity at the different production sites. 2. Non-cash fixed expenses in the amount of $7.4 million due to a decrease in fixed assets fair value. 3. Impairment of Goodwill amounting to $5.5 million. The Board of Directors appointed Mr. Isaac Dabah and Mr. Gideon Chitayat as directors. These directors will fill the vacancies created by the resignations of Mark Silver, J. Randall White and Anne E. Ziegler, who had been nominated by Sara Lee and resigned following the sale by Sara Lee of its shares in Delta Galil to GMM Capital, LLC. Mr. Dabah and Mr. Chitayat will serve as directors until the next annual general meeting of shareholders, which is scheduled for December 20, 2005. Each of them will be nominees for re-election at that meeting. Mr. Dabah, the Executive Director of GMM Capital, LLC, has been active in the textile and apparel business for approximately 25 years. Mr. Chitayat, who has taught at leading business schools in Israel and in the United States, has been a strategic consultant to leading Israeli companies. The proxy statement for the upcoming meeting, which will be available on or about November 27, 2005, will contain more complete biographies of each of the directors. Delta Galil is a leading global manufacturer of quality apparel sold under brands such as Calvin Klein, Hugo Boss, Nike, Ralph Lauren. Recognized for product innovation and development, Deltas products are sold worldwide through retailers including Wal-Mart, Marks & Spencer, Target, Victorias Secret, JC Penney, Hema, and others. Headquartered in Israel, Delta operates manufacturing facilities in Israel, Jordan, Egypt, Turkey, Eastern Europe ,North and Central America ,the Caribbean and the Far East. For more information, please visit our website: http://www.deltagalil.com. (This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on the current expectations of the management of DELTA Galil Industries Ltd. (the "Company") only, and are subject to a number of risk factors and uncertainties, including but not limited to our dependence on a few significant customers; our anticipated growth strategies; our intention to introduce new products; anticipated trends in our business; future expenditures for capital projects; and our ability to continue to control costs and maintain quality, which could cause the actual results or performance of the company to differ materially from those described therein. For a more detailed description of the risk factors and uncertainties affecting the company, refer to the Companys reports filed from time to time with the Securities and Exchange Commission.) Contacts: Yossi Hajaj Delta Galil Industries Ltd. Tel: +972-3-519-3744 U.S. Investors Kathy Price The Global Consulting Group Tel: 646-284-9430 CONDENSED CONSOLIDATED STATEMENT OF INCOME Nine months ended Three months ended September 30 September 30 2005 2004 2005 2004 ------- ------- ------- ------- In US $ thousand (except per share data) Revenues 514,294 487,067 171,957 176,472 Cost of revenues 436,552 392,468 144,734 142,775 Gross profit 77,742 94,599 27,223 33,697 Selling, marketing, general and administrative expenses: Selling and marketing expenses 65,502 60,107 22,566 20,947 General and administrative expenses 14,853 12,688 4,466 4,083 Capital gain (loss) from realization of assets (43) 168 (8) Impairment of fixed asset 7,415 7,415 Reorganization expenses 9,102 8,641 Goodwill impairment 5,505 5,505 Amortization of intangible asset 593 183 Operating income (loss) (25,271) 21,972 (21,561) 8,667 Financial expenses - net 7,159 4,954 2,718 1,799 Other income - net 300 958 Income (loss) before taxes on income (32,130) 17,976 (24,279) 6,868 Taxes on income (3,352) 3,807 (1,284) 1,365 Income (loss) after taxes on income (28,778) 14,169 (22,995) 5,503 Share in profits (loss) of an associated company (6) (100) 77 2 Minority interest in losses (profits) of subsidiaries - net 41 (1,199) 92 (471) Net income (loss) for the period (28,743) 12,870 (22,826) 5,034 Earnings (loss) per share - basic (1.54) 0.70 (1.22) 0.27 Earnings (loss) per share - diluted (1.54) 0.68 (1.22) 0.27 Weighted average number of shares - in thousands: Basic 18,695 18,460 18,695 18,477 Diluted 18,703 18,869 18,695 18,820 Before non recurring items net of taxes: Non recurring items in the third quarter and in the first nine months of the year include Reorganization expenses, impairments of assets and goodwill net of other income and capital gain (loss) from realization of assets. Operating income (loss) for the period (3,206) 21,804 (8) 8,667 ------ ------ ------ ----- Net income (loss) for the period (7,892) 12,750 (2,171) 5,034 ====== ====== ====== ===== Earning (loss) per share - diluted ($) (0.42) 0.67 (0.12) 0.27 ====== ====== ====== ===== CONDENSED CONSOLIDATED BALANCE SHEET September 30 December 31 2005 2004 2004 ------ ------ ------ In US $ thousands Assets: Current assets: Cash and cash equivalents 8,736 5,070 22,150 Accounts receivable: Trade 103,093 102,400 105,129 Other 13,567 14,978 10,627 Inventories 150,437 164,873 183,767 Deferred income taxes 7,243 5,257 3,675 Total current assets 283,076 292,578 325,348 Investments and long-term receivables 8,025 7,233 7,533 Property, plant and equipment 117,416 123,206 128,341 Other assets and deferred charges 53,399 54,594 58,497 Intangible asset 14,185 14,778 Total assets 476,101 477,611 534,497 Liabilities and shareholders equity: Current liabilities: Short-term bank credit 107,498 106,501 83,545 Trade 50,727 63,620 80,338 Other 39,514 36,736 34,083 Total current liabilities 197,739 206,857 197,966 Long-term liabilities: Bank loans and other liabilities 74,304 32,602 99,437 Liability for employee rights upon retirement 8,091 6,983 7,408 Deferred income taxes 1,526 6,491 4,894 Total long-term liabilities 83,921 46,076 111,739 Total liabilities 281,660 252,933 309,705 Minority interest 2,425 3,542 3,711 Shareholders equity 192,016 221,136 221,081 Total Liabilities and shareholders equity 476,101 477,611 534,497 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW Nine months ended Three months ended September 30 September 30 2005 2004 2005 2004 ------ ------ ------ ------ In US $ thousands Cash flows from operating activities: Net income (loss) for the period (28,743) 12,870 (22,826) 5,034 Adjustment required to reflect the cash flows from operating activities 29,338 (21,203) 31,953 (7,842) Net cash provided by (used in) operating activities 595 (8,333) 9,127 (2,808) Cash flows from investing activities: Purchase of fixed assets, net of investment grants (10,318) (11,229) (4,315) (3,684) Additional payment for the acquisition of subsidiaries (950) (9,704) (1,001) Proceeds from realization of fixed assets 300 780 29 40 Proceeds from realization of investment in associated company 2,640 Other (550) 276 170 651 Net cash used in investing activities (11,518) (17,237) (4,116) (3,994) Cash flows from financing activities: Long-term bank loans, net (20,333) 24,664 (9,222) 12,842 Dividend to shareholders (6,096) (1,854) Short-term bank credit - net 19,153 (5,095) 6,200 (5,177) Other (1,243) (532) (743) (453) Net cash provided by (used in) financing activities (2,423) 12,941 (3,765) 5,358 INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (13,346) (12,629) 1,246 (1,444) TRANSLATION IN DIFFERENCES IN CASH AND CASH EQUIVALENTS (68) BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 22,150 17,699 7,490 6,514 BALANCE OF CASH AND CASH EQUIVALENTS AT END OF PERIOD 8,736 5,070 8,736 5,070 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW Nine months ended Three months ended September 30 September 30 2005 2004 2005 2004 ------ ------ ------ ------ In US $ thousands Adjustment required to reflect the cash flows from operating activities: Income and expenses not involving cash flows: Depreciation and amortization 11,842 11,400 3,595 3,585 Reorganization expenses and impairment of assets 20,739 20,594 Deferred income taxes - net (6,928) (336) (968) 71 Capital gain from realization of investment in associated company (958) Capital losses (gain) from sales of fixed assets 43 (168) 8 Other (176) 1,599 (338) 702 25,520 11,537 22,891 4,358 Changes in operating assets and liabilities items: Increase in accounts receivable (1,643) (20,972) (3,197) (11,326) Increase (decrease) in accounts payable and accruals (27,713) 10,121 (4,089) (1,418) Decrease (increase) in inventories 33,174 (21,889) 16,348 544 3,818 (32,740) 9,062 (12,200) 29,338 (21,203) 31,953 (7,842)
health surveillance ©Copyright Cheviot Artus plc 2006.